Douglas Geenens
Psychiatry · Leawood, KSNPI 1265504971
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations.
Across 241 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$462
- AbbVie$383
- Sunovion Pharmaceuticals Inc.$362
- Vanda Pharmaceuticals Inc.$262
- Teva Pharmaceuticals USA, Inc.$232
- Axsome Therapeutics, Inc.$222
- plus $2K from 23 others
What the payments were for
- Food & beverage$3,973100%
- Education$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,992 in reported general payments places this provider in the 80th percentile of 259 psychiatry providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 26 | $42,268 |
| EpidiolexCannabidiol (Cbd) | 19 | $35,650 |
| RexultiBrexpiprazole | 20 | $34,441 |
| VyvanseLisdexamfetamine Dimesylate | 18 | $10,850 |
| Depakote ErDivalproex Sodium | 12 | $7,819 |
| Lurasidone Hcl | 17 | $7,041 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 175 | $6,527 |
| TrintellixVortioxetine Hydrobromide | 14 | $6,159 |
| Risperidone OdtRisperidone | 35 | $3,793 |
| Divalproex Sodium ErDivalproex Sodium | 49 | $3,704 |
| Oxcarbazepine | 16 | $3,419 |
| Methylphenidate ErMethylphenidate Hcl | 33 | $3,300 |
| Eszopiclone | 24 | $3,253 |
| Ziprasidone Hcl | 15 | $3,246 |
| Alprazolam | 352 | $2,976 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $383 | $42,26826 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $462 | $34,44120 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix | $122 | $17,00932 claims |
| Teva Pharmaceuticals USA, Inc.Loxapine | $232 | $80713 claims |
| Almatica Pharma LLCSertraline Hcl | $110 | $80078 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 259 psychiatry providers in Kansas.
Other psychiatry in Leawood
- Kevin MaysLeawood$548K
- Sonni ElliottLeawood$22K
- Andrew SegravesLeawood$19K
- Michael EversonLeawood$19K
- Steven SegravesLeawood$13K
- Lolitta AznaurovaLeawood$11K
- Christopher van HornLeawood$10K
- Sherman ColeLeawood$8K
- Erick BrownLeawood$8K
- Wade HachinskyLeawood$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.